China Universal Asset Management Company’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,687
Closed -$29.5K 520
2025
Q3
$29.5K Sell
18,687
-2,667
-12% -$4.63K ﹤0.01% 450
2025
Q2
$46.6K Buy
21,354
+196
+0.9% +$475 ﹤0.01% 422
2025
Q1
$57.8K Sell
21,158
-1,208
-5% -$4.76K 0.01% 406
2024
Q4
$93K Buy
22,366
+2,154
+11% +$8.14K 0.01% 401
2024
Q3
$78.6K Buy
20,212
+7,930
+65% +$33.4K 0.01% 372
2024
Q2
$48.1K Sell
12,282
-7,602
-38% -$32.7K 0.01% 359
2024
Q1
$83.3K Buy
19,884
+7,898
+66% +$37.1K 0.01% 388
2023
Q4
$56.3K Buy
11,986
+9,323
+350% +$36.3K 0.01% 361
2023
Q3
$8.31K Buy
2,663
+1,312
+97% +$5.28K ﹤0.01% 359
2023
Q2
$6.2K Sell
1,351
-31
-2% -$142 ﹤0.01% 351
2023
Q1
$6.84K Buy
1,382
+345
+33% +$1.7K ﹤0.01% 338
2022
Q4
$5.66K Buy
1,037
+85
+9% +$521 ﹤0.01% 284
2022
Q3
$6K Buy
+952
New +$5.31K ﹤0.01% 257

Other funds holding MXCT

China Universal Asset Management Company's MXCT Position: Q4 2025 in Review

China Universal Asset Management Company sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 18,687 shares — an estimated $29.5K sold.

China Universal Asset Management Company first reported a position in MXCT in Q3 2022 and held it in 13 quarters. The position peaked at $93K in Q4 2024. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • China Universal Asset Management Company reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 18,687 MaxCyte shares in Q4 2025, an estimated $29.5K.
  • China Universal Asset Management Company first reported a position in MaxCyte in Q3 2022 and held it in 13 quarters.
  • China Universal Asset Management Company's MaxCyte position peaked at $93K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.